MichaelJohnSwartzMD

Radiation Oncology • Rapid City, SD

Physician

Join to view full profile

Dr. Swartz is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Swartz's full profile

Already have an account?

Office
353 Fairmont Blvd
Rapid City, SD 57701
Phone+1 605-719-8559

Fax+1 605-719-2310
Is this information wrong?

Education & Training

Johns Hopkins UniversityResidency, Radiation Oncology, 2004 - 2008
MedStar Franklin Square Medical CenterInternship, Internal Medicine, 2003 - 2004
Johns Hopkins University School of MedicineClass of 2003

Certifications & Licensure

SD State Medical License Active through 2025
American Board of Radiology Radiation Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification MOSAIQ EMR, Elekta, 2012-2013

Clinical Trials

Radiation Therapy (WBI Versus PBI) in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer Start of enrollment: 2005 Mar 01
Completed
Not Applicable
Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Therapy in Treating Patients With a Rising Prostate Specific Antigen (PSA) After Surgery for Prostate Cancer Start of enrollment: 2008 Feb 01
Active, not recruiting
Phase 3
Paclitaxel, Cisplatin, and Radiation Therapy With or Without Cetuximab in Treating Patients With Locally Advanced Esophageal Cancer Start of enrollment: 2008 Jun 01
Completed
Phase 3
Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma Start of enrollment: 2009 Apr 15
Completed
Phase 3
Image-Guided Radiosurgery or Stereotactic Body Radiation Therapy in Treating Patients With Localized Spine Metastasis Start of enrollment: 2009 Nov 01
Completed
Phase 2, Phase 3
Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer Start of enrollment: 2009 Sep 01
Active, not recruiting
Phase 3
Radiation Therapy With or Without Cetuximab in Treating Patients Who Have Undergone Surgery for Locally Advanced Head and Neck Cancer Start of enrollment: 2009 Nov 01
Active, not recruiting
Phase 3
Chemotherapy and Pelvic Radiation Therapy With or Without Additional Chemotherapy in Treating Patients With High-Risk Early-Stage Cervical Cancer After Radical Hysterectomy Start of enrollment: 2009 Sep 01
Active, not recruiting
Phase 3
Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed by the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed by Surgery Start of enrollment: 2010 Apr 05
Active, not recruiting
Phase 3
Radiation Therapy in Treating Patients With Extensive Stage Small Cell Lung Cancer Start of enrollment: 2010 Mar 01
Completed
Phase 2
Radiation Therapy in Treating Women With Locally Recurrent Breast Cancer Previously Treated With Repeat Breast-Preserving Surgery Start of enrollment: 2010 Jun 01
Completed
Phase 2
Radiation Therapy With or Without Chemotherapy in Treating Patients With High-Risk Malignant Salivary Gland Tumors That Have Been Removed By Surgery Start of enrollment: 2011 Jan 01
Active, not recruiting
Phase 2
Avoiding the Hippocampus During Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases Start of enrollment: 2011 Mar 01
Completed
Phase 2
Radiation Therapy With Cisplatin or Cetuximab in Treating Patients With Oropharyngeal Cancer Start of enrollment: 2011 Jun 01
Active, not recruiting
Phase 3
Higher Per Daily Treatment-Dose Radiation Therapy or Standard Per Daily Treatment Radiation Therapy in Treating Patients With Early-Stage Breast Cancer That Was Removed by Surgery Start of enrollment: 2011 May 01
Active, not recruiting
Phase 3
Hormone Therapy, Radiation Therapy, and Steroid 17alpha-monooxygenase TAK-700 in Treating Patients With High-Risk Prostate Cancer Start of enrollment: 2012 May 01
Active, not recruiting
Phase 3
Standard Versus Intensity-Modulated Pelvic Radiation Therapy in Treating Patients With Endometrial or Cervical Cancer Start of enrollment: 2012 Nov 01
Completed
Phase 3
Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer Start of enrollment: 2013 Mar 22
Recruiting
Phase 2, Phase 3
Join now to see all

Publications & Presentations

PubMed

Intraoperative Electroencephalography Predicts Postoperative Seizures in Infants With Congenital Heart Disease.
Seltzer, L. E.,Swartz, M.,Kwon, J. M.,Burchfiel, J.,Alfieris, G. M.,Guillet, R.> ;Pediatr. Neurol.. 2014 Feb 11
41 citations
Early Mortality Risk Score: Identification of Poor Outcomes Following Upfront Surgery for Resectable Pancreatic Cancer
Charles C. Hsu, Christopher L. Wolfgang, Daniel A. Laheru, Timothy M. Pawlik, Michael J. Swartz, Jordan M. Winter, Raymond Robinson, Barish H. Edil, Amol Narang, Micha...> ;Journal of Gastrointestinal Surgery. 2012 Feb 7
45 citations
Adjuvant chemoradiotherapy after pancreatic resection for invasive carcinoma associated with intraductal papillary mucinous neoplasm of the pancreas.
Michael J. Swartz, Charles C. Hsu, Timothy M. Pawlik, Jordan M. Winter, Ralph H. Hruban, Mehmet L. Guler, Richard D. Schulick, John L. Cameron, Daniel A. Laheru, Chris...> ;International Journal of Radiation Oncology, Biology, Physics. 2010 Mar 1
178 citations
Adjuvant Chemoradiation for Pancreatic Adenocarcinoma: The Johns Hopkins Hospital—Mayo Clinic Collaborative Study
Charles C. Hsu, Joseph M. Herman, Michele M. Corsini, Jordan M. Winter, Matthew D. Callister, Michael G. Haddock, John L. Cameron, Timothy M. Pawlik, Richard D. Schuli...> ;Annals of Surgical Oncology. 2010 Jan 20
60 citations
Resected pancreatic adenosquamous carcinoma: clinicopathologic review and evaluation of adjuvant chemotherapy and radiation in 38 patients
K. Ranh Voong, Jon M. Davison, Timothy M. Pawlik, Manuel O. Uy, Charles C. Hsu, Jordan M. Winter, Ralph H. Hruban, Daniel A. Laheru, Sonali Rudra, Michael J. Swartz, H...> ;Human Pathology. 2010 Jan 1
1 citations
The role of radiation therapy in the management of lung, prostate and colorectal cancer in South Dakota.
Michael J Swartz, Daniel G. Petereit> ;South Dakota Medicine. 2010 Jan 1
The role of radiation therapy in the management of breast cancer in South Dakota.
Michael J Swartz, Daniel G. Petereit> ;South Dakota Medicine. 2010 Jan 1
60 citations
Determining Pattern of Recurrence Following Pancreaticoduodenectomy and Adjuvant 5-Flurouracil-Based Chemoradiation Therapy: Effect of Number of Metastatic Lymph Nodes...
Bolanle Asiyanbola, Ana Gleisner, Joseph M. Herman, Michael A. Choti, Christopher L. Wolfgang, Michael J. Swartz, Barish H. Edil, Richard D. Schulick, John L. Cameron,...> ;Journal of Gastrointestinal Surgery. 2009 Apr 1
48 citations
Patterns of Recurrence Following Liver Resection for Colorectal Metastases: Effect of Primary Rectal Tumor Site
Lia Assumpcao, Michael A. Choti, Ana Gleisner, Richard D. Schulick, Michael J. Swartz, Joseph M. Herman, Susan L. Gearhart, Timothy M. Pawlik> ;Archives of Surgery. 2008 Aug 18
271 citations
Analysis of Fluorouracil-Based Adjuvant Chemotherapy and Radiation After Pancreaticoduodenectomy for Ductal Adenocarcinoma of the Pancreas: Results of a Large, Prospec...
Joseph M. Herman, Michael J. Swartz, Charles C. Hsu, Jordan M. Winter, Timothy M. Pawlik, Elizabeth A. Sugar, Ray Robinson, Daniel A. Laheru, Elizabeth M. Jaffee, Ralp...> ;Journal of Clinical Oncology. 2008 Jul 20
13 citations
Outcomes of Adjuvant Chemoradiation After Pancreaticoduodenectomy With Mesenterico-Portal Vein Resection for Adenocarcinoma of the Pancreas
Boris Hristov, Sushanth Reddy, Steven H. Lin, John L. Cameron, Timothy M. Pawlik, Ralph H. Hruban, Michael J. Swartz, Barish H. Edil, Clinton D. Kemp, Christopher L. W...> ;International Journal of Radiation Oncology, Biology, Physics. 2007 Nov 1
Radiation therapy for prostate cancer: the role for dose escalation.
Michael J. Swartz, Kristin Janson, Theodore L. DeWeese, Danny Y. Song> ;Comprehensive Therapy. 2007 Oct 19
32 citations
Adjuvant concurrent chemoradiation for node-positive adenocarcinoma of the duodenum.
Michael J. Swartz, Michael Hughes, Deborah A. Frassica, Joseph M. Herman, Charles J. Yeo, Taylor S. Riall, Keith D. Lillemoe, John L. Cameron, Ross C. Donehower, Danie...> ;Archives of Surgery. 2007 Mar 1
130 citations
In vivo Therapeutic Responses Contingent on Fanconi Anemia/BRCA2 Status of the Tumor
Michiel S. van der Heijden, Jonathan R. Brody, David A. Dezentje, Eike Gallmeier, Steven C. Cunningham, Michael J. Swartz, Angelo M. DeMarzo, G. Johan A. Offerhaus, Wi...> ;Clinical Cancer Research. 2005 Oct 15
16 citations
Hematopoietic Progenitor Stem Cell Homing in Mice Lethally Irradiated with Ionizing Radiation at Differing Dose Rates
Spencer J. Collis, Sara Neutzel, Travis L. Thompson, Michael J. Swartz, Larry E. Dillehay, Michael I. Collector, Saul J. Sharkis, Theodore L. DeWeese> ;Radiation Research. 2004 Jul 1
129 citations
Enhanced radiation and chemotherapy-mediated cell killing of human cancer cells by small inhibitory RNA silencing of DNA repair factors
Spencer J. Collis, Michael J. Swartz, William G. Nelson, Theodore L. DeWeese> ;Cancer Research. 2003 Apr 1
200 citations
MUC4 expression increases progressively in pancreatic intraepithelial neoplasia.
Michael J. Swartz, Surinder K. Batra, Grish C. Varshney, Michael A. Hollingsworth, Charles J. Yeo, John L. Cameron, Robb E. Wilentz, Ralph H. Hruban, Pedram Argani> ;American Journal of Clinical Pathology. 2002 May 1
Join now to see all

Press Mentions

BioSpace Movers & Shakers, Aug. 27August 27th, 2021
AstraZeneca Promotes Oncology Exec to CMO; Pfizer Replaces Retiring Chief Dealmaker as War Chest ExpandsAugust 27th, 2021
MediXall Group Hires Leading PR Firm, TransMedia Group, to Drive Brand Awareness & Media Relations to Propel Health Karma on Its Next Phase of GrowthAugust 5th, 2021
Join now to see all

Hospital Affiliations

Monument Health Rapid City HospitalRapid City, South Dakota
Monument Health Custer HospitalCuster, South Dakota
Black Hills HCSFort Meade, South Dakota

MichaelJohnSwartzMD

Dr. Swartz is on Doximity

Education & Training

Certifications & Licensure

Awards, Honors, & Recognition

Clinical Trials

Publications & Presentations

Press Mentions

Hospital Affiliations

Viewing the full profile is available to verified healthcare professionals only.